ASF CONNECT featuring Kevin Conroy, CEO of Exact Sciences | May 21, 2021 by American Swiss Foundation published on 2021-05-26T14:17:22Z On Friday, May 21, 2021, we hosted an ASF CONNECT program featuring Exact Sciences CEO Kevin Conroy(YL 2010) in conversation with Bettina Schaller(YL 2011), President of the Young Leaders Alumni Foundation. Kevin Conroy is the Chief Executive Officer, President, and Chairman of the Board of Exact Sciences, one of the world’s premier cancer diagnostics companies with more than 5,500 employees. He has led Exact Sciences through the development, clinical trial, regulatory approval, and commercialization of its noninvasive colorectal cancer screening test, Cologuard®. In 2019, Exact Sciences’ acquisition of Genomic Health, Inc., united two of the industry’s strongest brands, Cologuard and Oncotype DX®, and established the company’s position as the global leader in advanced cancer diagnostics. A native of Flint, Michigan, he holds a Bachelor of Science degree in electrical engineering from Michigan State University and earned his Juris Doctorate from the University of Michigan Law School. He serves as a director of Epizyme, Inc. and Adaptive Biotechnology Corporation. Genre News & Politics